Pioneering cancer test company wants court to slow potential sale of Invitae’s cancer-monitoring products

A U.S. District Courtroom jury mentioned final 12 months that Invitae owed Natera near $20 million for infringing three patents round personalised most cancers monitoring.

Article by [author-name] (c) San Francisco Business News - Local San Francisco News | The San Francisco Business Times - Read full story here.

1 2 3 4 5 6 7 8